MiR-181b sensitizes glioma cells to teniposide by targeting MDM2.
Sun YC, Wang J, Guo CC, Sai K, Wang J, Chen FR, Yang QY, Chen YS, Wang J, To TS, Zhang ZP, Mu YG, Chen ZP.
Sun YC, et al. Among authors: chen zp, chen fr, chen ys.
BMC Cancer. 2014 Aug 25;14:611. doi: 10.1186/1471-2407-14-611.
BMC Cancer. 2014.
PMID: 25151861
Free PMC article.